Calcium intravenous infsuion
PreclinicalSmall molecule
Calcium intravenous infsuion is one of 51 small molecule programs targeting Ovarian Hyperstimulation Syndrome. It is currently in Preclinical.
3
Indications
9
Total Trials
6
Active Trials
50
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
61 competitors in Post Operative Pain
#DrugCompanyPhaseTrials
1Marcaine
IInnocoll
Approved
Duragesic
CCephalon
Approved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
Ketalar
AAultman Health Foundation
Approved
Oxycontin
PProtega
Approved
Epsom Salt
FFresenius Kabi USA, LLC
Approved
Tylenol
KKenvue Brands
Approved
Suboxone
IIndivior Inc.
Approved
Achromycin V
WWyeth-Lederle Vaccines
Approved
EXPAREL
Pacira Pharmaceuticals, IncApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Post Operative Pain3 trials
Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp
Completed·—·Phase 4·NCT03692286·30 enrolled
Periodontitis2 trials
Inflammatory Cytokines1 trial
Efficacy of 810 nm Diode Laser Disinfection on Inflammatory Cytokines and Postoperative Pain After Endodontic Retreatment
Recruiting·—·N/A·NCT07141459·52 enrolled
Periapical Lesion1 trial
Intracanal Dressing1 trial
Effect of Bio-C Temp Versus Calcium Ydroxide as Intracanal Dressings on Postoperative Pain Intensity and Periapical MMP-9 Level in Patients With Necrotic Pulp
Not yet recruiting·—·Phase 1·NCT07101029·30 enrolled
1 more indication
Ovarian Hyperstimulation Syndrome1 trial
Ovarian Hyperstimulation Syndrome Using Calcium Infusion
Unknown status·—·N/A·NCT05198128·200 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMansoura University